These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6441626)

  • 41. Neridronic acid for the treatment of bone metabolic diseases.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Adami S
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1305-11. PubMed ID: 19761412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracellular matrix in tooth cementum and mantle dentin: localization of osteopontin and other noncollagenous proteins, plasma proteins, and glycoconjugates by electron microscopy.
    McKee MD; Zalzal S; Nanci A
    Anat Rec; 1996 Jun; 245(2):293-312. PubMed ID: 8769669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein.
    Triffitt JT
    Calcif Tissue Res; 1976 Nov; 22(1):27-33. PubMed ID: 1000340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
    Toh SH; Claunch BC; Brown PH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic bone disease in adolescents: recognition, evaluation, treatment, and prevention.
    Kamboj MK
    Adolesc Med State Art Rev; 2007 May; 18(1):24-46, viii. PubMed ID: 18605389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased bone strontium levels in hemodialysis patients with osteomalacia.
    D'Haese PC; Schrooten I; Goodman WG; Cabrera WE; Lamberts LV; Elseviers MM; Couttenye MM; De Broe ME
    Kidney Int; 2000 Mar; 57(3):1107-14. PubMed ID: 10720963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new alpha 2HS-glycoprotein typing by isoelectric focusing.
    Umetsu K; Kashimura S; Ikeda N; Suzuki T
    Hum Genet; 1984; 67(1):70-1. PubMed ID: 6745928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone collagenase in assessment of the clinical course of metabolic bone disease.
    Gardner B; Wallach S; Gray H; Baker RK
    Surg Forum; 1971; 22():435-7. PubMed ID: 4330605
    [No Abstract]   [Full Text] [Related]  

  • 53. Fluoride therapy in metabolic bone disease.
    Spencer H; Kramer L; Wiatrowski E; Lender M
    Isr J Med Sci; 1984 May; 20(5):373-80. PubMed ID: 6469556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractures in brittle bone diseases.
    Mitchell DC
    Orthop Clin North Am; 1972 Nov; 3(3):787-92. PubMed ID: 4640592
    [No Abstract]   [Full Text] [Related]  

  • 55. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Disorder of bone quality in Paget's disease].
    Tsurukami H
    Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that the alpha 2HS glycoprotein receptor and the Epstein-Barr virus nuclear antigen (EBNA) are identical.
    Lewis JG; André CM
    FEBS Lett; 1983 Sep; 161(2):306-10. PubMed ID: 6311627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone quality changes associated with aging and disease: a review.
    Boskey AL; Imbert L
    Ann N Y Acad Sci; 2017 Dec; 1410(1):93-106. PubMed ID: 29265417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for abnormality of bone-matrix proteins in osteogenesis imperfecta.
    Dickson IR; Millar EA; Veis A
    Lancet; 1975 Sep; 2(7935):586-7. PubMed ID: 51410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathological fractures in osteopathies and bony dysplasias.
    Campanacci M; Giunti A; Leonessa C; Pagani P; Trentani C
    Ital J Orthop Traumatol; 1975; Suppl 1():7-45. PubMed ID: 789287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.